Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Ozempic: The Game-Changer For Weight Loss? Weight Loss.meds
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-27
"Is Ozempic the future of weight loss? 🌟 Originally developed to treat diabetes, this GLP-1 agonist is making headlines for its incredible weight loss results—helping people lose up to 15% of their body weight! But is it the ultimate solution, or just part of the puzzle? Watch to learn more about how it works, its side effects, and whether it’s right for you. Don’t forget to like, comment, and subscribe for more health and pharma insights!"
"💬 What’s your take on Ozempic? Share your thoughts below!"
"🔔 Follow us for the latest health trends and updates!"
"📚 Learn more about the science behind today’s top health breakthroughs on our channel."
#Ozempic #WeightLossJourney #HealthRevolution #WeightLossTips #ObesityCrisis #PharmaInsights #GLP1 #Semaglutide #HealthyLiving #MedicalBreakthrough #FutureOfMedicine #WeightLossSolution
Ozempic: The Game-Changer For Weight Loss? For Country: United States. City: El Monte, Modesto, Orange, Santa Ana, Tallahassee
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication